In Brief
The most critical stage in melanoma metastasis initiation is the radial to vertical growth transition, yet the triggers of this transition remain elusive. Golan et al. discovered that direct contact of melanoma cells with the remote epidermal layer triggers vertical invasion via Notch signaling activation, the latter inhibiting MITF function.
INTRODUCTION
Malignant melanoma is the most aggressive and treatmentresistant human skin cancer (Gaggioli and Sahai, 2007) . Development of malignant melanoma involves several distinct stages, with movement across the basal membrane considered a critical event, yet the molecular events underlying acquisition of invasion capability remain elusive.
Human epidermal and dermal layers are separated by a basal epidermal layer (Hsu et al., 2002) composed of undifferentiated, self-renewing keratinocytes and melanocytes (Balint et al., 2005) . Keratinocytes at increasing stages of terminal differentiation are found in the upper epidermal layer (Hsu et al., 2002) . The dermis consists of mesenchymal components (i.e., fibroblasts) and, in contrast to the epidermis, includes blood vessels (Hsu et al., 2002) . Melanoma primary stage involves proliferation of cells from the basal epidermis toward the upper epidermis and is termed melanoma in situ (Gaggioli and Sahai, 2007) . In situ melanomas do not metastasize. Metastasis requires transition into the invasive melanoma stage, characterized by invasion of the dermis and increased vascularization that allows cells to spread (Gaggioli and Sahai, 2007) . Notably, as melanocytes transform from melanoma in situ to invasive melanoma, they encounter different tumor microenvironments consisting of various types of neighboring cells in the epidermal and dermal layers. In this study, we examined the potential influence of these various neighboring cells on invasion initiation.
Since activation of Notch signaling is known to contribute to melanoma progression (Pinnix and Herlyn, 2007) , although it is not known which cells serve as the sender cells, we focused on this communication pathway. Notch signaling is mediated by direct interactions between membrane-bound Notch receptors (Notch1-4) on the receiver cells and Notch ligands (Delta-like or Jagged) on the sender cells (Balint et al., 2005; Osawa and Fisher, 2008) . Upon activation, the Notch receptor intracellular domain (NICD) is cleaved and translocates into the nucleus where, together with the recombination signal binding protein J kappa (RBPJK), it functions as a transcriptional regulator. Depending on associated proteins, RBPJK may act as an activator or a repressor of transcription (Guruharsha et al., 2012) . We have recently identified the microphthalmia-associated transcription factor (MITF) as a co-factor of RBPJK (Tabach et al., 2013) . Notably, MITF is a key regulator of melanoma progression (Garraway et al., 2005) but also serves as a central inhibitor of melanoma invasion (Carreira et al., 2006; Levy et al., 2010) .
In addition to directly regulating expression of genes, MITF regulates expression of a miRNA called miR-211 (Levy et al., 2010) . miRNAs are short, non-coding RNAs that serve as sequence-specific negative regulators of gene expression (Ambros, 2004; Bartel, 2004) .
Here we found that contact between melanocytes and differentiated keratinocytes activates Notch signaling in melanoma cells. Further, we discovered a previously undescribed role of MITF, together with RBPJK, as a transcriptional repressor of miR-222/221. We show that NICD translocation into the nucleus results in removal of MITF/RBPJK from the miR-222/ 221 promoter, which leads to expression of miR-222/221. Moreover, we provide evidence that miR-222/221 expression enables acquisition of invasion capability. In summary, we establish that only when melanoma cells reach a Notch-expressing microenvironment do the cells acquire the ability to migrate through the basal membrane of the epidermis to the dermis.
RESULTS

Interaction of Melanoma Cells with Differentiated Keratinocytes Promotes Invasion
It was previously shown that skin architecture is essential for melanoma to gain invasion capabilities due to unknown reasons (Van Kilsdonk et al., 2010) . We hypothesized that exposure to different types of neighboring cells during disease progression contributes to this transition. To investigate this model, melanoma cells with no intrinsic invasive abilities (Figure S1A) (Levy et al., 2010) were co-cultured (in 1:5 ratio) with primary cells characterizing human skin: differentiated keratinocytes, basal keratinocytes, fibroblasts, or endothelial cells, and then invasion capability was analyzed using an in vitro matrigel invasion assay ( Figure 1A ). Co-culture with dermal endothelial cells served as a positive control (Howard et al., 2013) . Remarkably, melanoma cells gained significant invasion ability following co-culture with differentiated keratinocytes, (p < 0.05). No invasion capability was observed after melanoma cells were co-cultured with basal keratinocytes or fibroblasts ( Figure 1A) . Interestingly, melanoma cells grow at WM3526 cells stably transfected with a luciferase reporter were co-cultured with the indicated primary human cell types. Co-cultured cells were co-grafted into immunodeficient mice and analyzed using bioluminescence live imaging. One representative image of bioluminescence in the lung is shown for each primary cell type. Graph represents the average bioluminescence activity in the lung and is indicative of metastasis. Error bars represent ± SEM, * indicates p < 0.05 (n = 4). See also Figure S1 . a higher rate when co-cultured with endothelial cells than alone both in vitro ( Figure S1B ) and in vivo ( Figure S1C ). In order to exclude the possibility that differential detection of invading cells was due to differences in growth rates, the number of invading cells was normalized to the total number of melanoma cells seeded.
An indirect marker of invasion capability is reduction in melanoma pigment (Pinner et al., 2009 ). Accordingly, co-culture of melanoma cells with differentiated keratinocytes resulted in hypopigmentation ( Figure 1B) . Next, we employed a mouse xenograft model. Melanoma cells with little invasive capability that constitutively express luciferase were co-cultured with each kind of primary skin cell before being subcutaneously injected into immunocompromised mice ( Figure 1C ). Six weeks later, live bioluminescence analysis was performed. Co-culture of melanoma cells with differentiated keratinocytes and endothelial cells, but not with basal keratinocytes or fibroblasts, was observed to result in significant numbers of lung metastases ( Figure 1C ). No changes in pigmentation or invasion ability resulted when melanoma cells were grown in the same media used to culture neighboring cells or in media taken from cultures of neighboring cells (data not shown). This suggested that the melanoma invasion trigger was not a secreted factor but was rather due to direct contact with neighboring cells. Taken together, these data demonstrate that direct interaction of melanoma cells with differentiated keratinocytes triggers melanoma invasion.
Differentiated Keratinocytes Induce Notch Signaling in Melanoma Cells
During epidermis development Wnt, FGF, BMP, and Notch signaling are known to be active (Fuchs, 2007) . However, since Notch signaling is the classical pathway induced by cell-cell interactions, we further explored this communication pathway as mediating triggering of melanoma invasion.
First we confirmed that melanoma cells are capable of transducing Notch signaling. To this end, we measured levels of Notch receptor expression in melanoma cells. We employed non-invasive melanoma cells (WM3682, WM3526) and cells with high invasive potential (WM1716, WM3314) (Levy et al., 2010) . Each melanoma cell line was found to express a detectable level of the Notch receptor, indicating that all melanoma cells have the potential to activate the Notch cascade upon interaction with ligand ( Figures 2A, S2A , and S2B).
Next, we examined if differentiated keratinocytes indeed express Notch ligands in normal human skin and serve as the sender cells. To this end, skin sections were subjected to immunofluorescence analysis using antibodies directed against each Notch ligand, Jagged1 and Delta-like-1 (DLL1). Remarkably, expression of some Notch ligands was detectable only in the upper layer of the epidermis ( Figures 2B and S2C ). Endothelial cells served as an internal positive control (Howard et al., 2013) . Accordingly, Notch activity, as indicated by the presence of nuclear NICD, was observed similarly only in the upper epidermis ( Figure S2D ) in line with a previous study (Watt et al., 2008) . As expected, normal melanocytes were located in the basal layer (Gaggioli and Sahai, 2007) and displayed MITF expression ( Figure 2B ) but no Notch activity ( Figure S2D ). To characterize more precisely whether Notch ligand expression by differentiated keratinocytes correlates with induction of Notch activity in melanoma, we employed a coculturing assay. Briefly, a melanoma cell line was stably transfected with a GFP-expressing plasmid and also with a Notch signaling mCherry reporter (Sprinzak et al., 2010) . This GFP-expressing melanoma cell line was then co-cultured with each of the primary human skin cells. Each experiment was repeated at least four times with different donors serving as the source for the cultured cells. Keratinocyte differentiation was validated using known markers, K14 and involucrin ( Figure S2E ). Remarkably, co-culture of melanoma cells with differentiated keratinocytes, but not with basal keratinocytes or fibroblasts, resulted in significant Notch activity ( Figures 2C and S2F ). This Notch activity was abrogated by presence of the Notch inhibitor gamma secretase inhibitor (DAPT) ( Figure 2C ). Importantly, differentiated keratinocytes lost their ability to induce melanoma invasion in the presence of DAPT ( Figure 2D ), indicating that differenti- ated keratinocyte induction of invasion is Notch dependent. Moreover, DLL1 reduction virtually abolished the abilities of differentiated keratinocytes to induce invasion (p < 0.05) and to activate Notch signaling in melanoma cells (p < 0.05) ( Figures S2G-S2I ). Taken together, these data indicate that differentiated keratinocytes activate Notch signaling in melanoma cells, triggering acquisition of invasion capabilities. To further evaluate the clinical relevance of our findings, we analyzed melanoma patient samples. In each patient specimen we analyzed areas of normal, in situ, and invasive melanomas in order to follow disease progression. Normal melanocytes, stained by melan-A, were observed in the basal layer in normal sections, and as melanoma progressed, melanocytic origin cells were observed in the upper epidermal layers and the dermis (Figures 3A and S3A-S3C). DLL1 was observed only in the upper epidermal layer (Figures 3A and S3A-S3C) in all areas irrespective of disease progression. Notably, dermal invasion of melanoma cells was observed to correlate precisely with direct interaction with DLL1-expressing cells. As long as melanoma cells were at a distance from DLL1-expressing cells, the disease remained in the superficially epidermal spreading phase . In accordance with this, most of the melanoma cells in the radial growth phase were in direct contact with differentiated keratinocytes as shown by staining with Keratin 10 ( Figure S3D ). Accordingly, Notch signaling activity was observed only in invasive melanoma ( Figure 3B ). Taken together, our data suggest that the melanoma in situ to invasive growth transition is triggered by the Notch-inducing microenvironment of the upper epidermal layer.
Increased miR-222/221 Expression in Melanoma Cells upon Interaction with Differentiated Keratinocyte Promotes Invasion
Next we considered the downstream molecular effectors of Notch signaling activation. In light of our previous research demonstrating that MITF and RBPJK cooperate in induction of miR-211 (Tabach et al., 2013) , we reasoned that the Notch signal could be transduced via NICD/RBPJK/MITF, and we focused on miRNAs as downstream candidates of this axis. First, an miRNA small-RNA-seq was performed on melanoma cells upon Notch signaling activation by culturing on DLL1-coated plates. Of the 1,488 miRNAs detected, 523 were differentially expressed (fold change R 2). Interestingly, about 90% of known MITF-bound miRNAs promoters (Ozsolak et al., 2008) were detected at the differentially expressed miRNAs (p = 3.26e-6). Among these five were previously reported by us (Levy et al., 2010) to promote (miR-221, miR-222 and miR-20b) or inhibit (let-7a, d) melanoma invasion ( Figure 4A and Table S1 ). Both miR-222/221 cluster and miR-20b are known to have pro-invasive activity (Felicetti et al., 2008; Levy et al., 2010) ; however, the miR-222/221 cluster exhibits four times higher fold change upon Notch activation. Hence, we further focused on miR-222/221 as a downstream target of the NICD/RBPJK/MITF axis and validated its upregulation in melanoma upon co-culturing with differentiated keratinocytes ( Figure S4A ). Interestingly, we noted four RBPJK DNA binding sites in the miR-222/221 promoter.
Next, we examined if interaction of melanoma cells with differentiated keratinocytes results in upregulation of miR-222/221. (Ozsolak et al., 2007) to be bound at their promotor by MITF, and miRNAs shown to promote melanoma invasion (Levy et al., 2010) . *p = 3.26e-6. (B) Left panel: Experimental design. Right panel: WM3682 cells were transfected with a luciferase reporter driven by the miR-222/221 promoter. Transfected cells were co-cultured with the indicated primary human cell types and luciferase activity was measured. Error bars represent ± SEM, * indicates p < 0.05 (n = 4). (C) WM3682 cells were stably transfected with a vector expressing miR-222 or scrambled miRNA (control) and injected subcutaneously into immunodeficient mice. One representative image of H&E staining of lung tissue is shown; arrow indicates metastases. (D) WM3314 and WM1716 cells were transfected with miR-222 antagomiR (anti222), miR-221 antagomiR (anti221), both antagomiRs (anti222/221), or antagomiR control; WM3682 and WM3526 cells were transfected with miR-222 mimic, miR-221 mimic, both miR-222/221 mimics, or scrambled control, and an invasion assay was performed. Error bars represent ± SEM, * indicates p < 0.05 (n = 4). (E) Upper panels: miR-222 expression levels in normal human skin, benign nevi, superficial-spreading melanomas, and invasive melanoma were detected by in situ hybridization (green). DAPI-stained nuclei appear blue. Lower panels: H&E staining of same magnification and location. White dashed lines represent epidermal-dermal junction.
(F) WM3526 cells were transfected with anti-miR-222/221, siMITF, anti-miR-222/221 plus siMITF, or scrambled siRNA before being subjected to an invasion assay. Error bars represent ± SEM, * indicates p < 0.05 (n = 4). See also Figure S4 .
Melanoma cells were transfected with the miR-222/221 promoter reporter and co-cultured with the different neighbors within the melanoma cell microenvironment. In line with our earlier results, only differentiated keratinocytes triggered transcriptional activation of the miR-222/221 promoter in melanoma cells ( Figure 4B ). According to our expression profiles of melanoma cells (Bell et al., 2014) we determined that non-invasive melanoma cells express low miR-222/221 levels (WM3682, WM3526) whereas melanoma cells with high invasive potential (WM1716, WM3314) express high miR-222/221 levels. Next, to examine more directly if miR-222/221 expression is involved in acquisition of invasion capability, we employed the mouse xenograft model. Melanoma cells with low invasive capability were stably transfected with a miR-222 expression vector or a scrambled miRNA vector and injected subcutaneously into immunodeficient mice. Three weeks post injection, significantly more lung and liver metastases were found only in the mice injected with melanoma cells stably expressing miR-222 ( Figures 4C and S4B) . Conversely, knockdown of miR-222/221 levels using antagomiRs was observed to reduce the number of invading melanoma cells (Figures 4C and S4C) (p < 0.05). Overexpression of a control vector did not impact the number of invading cells.
Next, we evaluated the expression levels of miR-222 in normal human skin, benign nevi, in situ melanoma, and invasive melanoma by in situ hybridization. In normal skin, nevus, and in situ melanomas, miR-222/221 was expressed solely by keratinocytes in the upper epidermis ( Figure 4D ). In contrast, in the invasive melanoma specimen, miR-222/221 was expressed by most melanoma cells ( Figure 4D ). Melan-A staining confirmed that the cells that expressed miR-222/221 were of melanocytic origin ( Figure S4D ). These results indicate that miR-222/221 upregulation is characteristic of invasive melanoma.
We next examined if the capability of miR-222/221 to induce invasion is effected by MITF and vice versa. Cells with high MITF levels and low invasion capability were transfected with siMITF and observed to exhibit a dramatic increase in invasion capability (p < 0.05), in line with previous studies (Levy et al., 2010) . Notably, when cells were simultaneously transfected with siMITF and miR-222/221 antagomiR, this reduction in invasion capability was significantly reversed (p < 0.05) ( Figures 4E  and S4E ). As a complementary rescue experiment, highly invasive melanoma cells were transfected with a vector for expression of MITF; this resulted in significant reduction in invasion capability (p < 0.05). However, when cells were simultaneously transfected with the MITF vector and miR-222/221 mimic, this reduction was reversed (Figures S4F). Transfection with the miR-222/221 antagomiR alone had no effect on cell invasion ( Figure 4E ), since these cells have very low basal miR-222/221 levels. These results suggest that MITF influences melanoma invasion by repressing miR-222/221.
MITF Blocks Melanoma Invasion by Repressing miR-222/221 Expression
To examine more directly if MITF regulates miR-222/221 expression, we inspected the human miR-222/221 promoter ($2.1 kb upstream to TSS) and identified two conserved MITF consensus binding sequences (5 0 -CATGTG-3 0 , E-Box elements). The ability of MITF to bind the E-Box sequences in miR-222/221 promoter was verified using the electrophoretic mobility shift assay (EMSA) (Figures 5A and S5A) . Next, the capability of MITF to regulate miR-222/221 expression was demonstrated using reporter construct whereby luciferase expression was driven by the miR-222/221 promoter region. We found that luciferase expression was indeed inhibited by endogenous MITF, and this inhibition was diminished by mutation of the two E-Box elements ( Figure 5B ). Mutations in the E-Box region resulted in no change in expression from the reporter in cells with low MITF levels ( Figure S5B ). Importantly, expression from the miR-222/ 221 promoter was up-and downregulated upon MITF depletion or overexpression in an E-Box-dependent manner, respectively. Of note, a luciferase reporter driven by the miR-211 promoter (previously identified as positively regulated by MITF) was regulated oppositely, namely down-and upregulated upon MITF depletion or overexpression in an E-Box-dependent manner, respectively ( Figure S5C ). These results indicate that MITF binds the miR-222/221 promoter and exerts negative regulation of expression.
To corroborate that MITF binds the miR-222/221 promoter in vivo, we conducted chromatin immunoprecipitation (ChIP) analysis of melanoma cell extracts. We found that MITF is detectably bound to the miR-222/221 promoter ( Figure 5C ) and also to the miR-211 promoter ( Figure S5D ). No binding was detected to a downstream region ( Figure S5E ), and the amount of bound MITF mirrored MITF expression levels. Next, we examined using ChIP analysis if MITF occupancy of the miR-222/ 221 promoter is accompanied by epigenetic changes (Levy and Fisher, 2011 ) associated with inhibition of expression. To this end, we monitored the levels of histone3 (H3) trimethylation at lysine 4 (H3K4me3), as a marker of transcriptionally active chromatin, and H3K27 trimethylation (H3K27me3) as characteristic of inactive genes (Li et al., 2007) . We observed that MITF depletion was accompanied by an increase in H3K4me3 and a decrease in H3K27me3 modifications at the miR-222/221 promoter ( Figure 5C ; p < 0.05), supporting that MITF negatively regulates miR-222/221 expression.
Next, we took advantage of cultured human melanoma cells that express high levels (WM3682, 451LU) or low levels (WM1716, WM3314) of MITF. We manipulated MITF expression in these lines and monitored miR-222/221 levels. MITF depletion resulted in increased (p < 0.05) levels of mature, pre-, and primiR-222/221 ( Figures 5D and S5F-S5J ). This observation indicates that MITF-dependent regulation of miR-222/221 expression is at the transcriptional rather than post-transcriptional level. Overexpression of MITF was found to result in reduced levels of miR-222/221 ( Figures 5D and S5F-S5I ). In contrast, miR-211 was induced by MITF overexpression and repressed by MITF depletion.
Finally, we surveyed sample-matched mRNA/miRNA expression profiles (Bell et al., 2014; Lin et al., 2008) and observed a significant (p < 0.05) inverse correlation between MITF and miR-222/221 levels ( Figure 5E ). In contrast, as expected, a significant positive correlation was observed between MITF and miR-211 (Levy et al., 2010) . Similarly, mature miR-222/221 and MITF protein expression levels were found to exhibit an inverse correlation ( Figure 5F ). Taken together, our data demonstrate that MITF represses miR-222/221 expression by epigenetically affecting the promoter.
MITF Cooperates with RBPJK to Repress Transcription of miR-222/221 in Melanoma Cells
Next we examined the molecular mechanism of how Notch signaling is transduced to MITF/miR-222/221. In the absence of NICD, RBPJK forms a repressor complex (Liefke et al., 2010) . Therefore, we investigated if the negative regulation of miR-222/221 by MITF requires RBPJK. Inspection of the miR-222/221 promoter revealed four conserved RBPJK binding sites (5 0 -TTCCCAC/G-3 0 , positions À1004 and À764; 5 0 -ATGG GAG-3 0 , position À612; 5 0 -TGGGAAT-3 0 , position À112) (Chang et al., 2010) , which we will refer to henceforth as R-Boxes. Furthermore, we found that RBPJK levels are similar across various melanoma cell lines ( Figure S6A ), while MITF and miR-222/221 levels are inversely correlated ( Figure 5F ). RBPJK overexpression and depletion ( Figure S5J ) in cells expressing high levels of MITF was observed to reduce and induce, respectively, mature and pre-miR-222/221 levels ( Figures 6A and S6B ). In contrast, RBPJK overexpression and depletion in cells expressing low levels of MITF was observed to induce and reduce, respectively, mature and pre-miR-222/221 levels ( Figure 6A ). These results support that the inhibitory effect of RBPJK on the miR-222/221 promoter depends on the presence of MITF. Notably, since RBPJK requires Notch signaling activation to induce gene expression, we suspect that the observed activation of miR-222/221 transcription by RBPJK in the presence of low MITF levels is due to constitutively active Notch signaling in these highly invasive cells ( Figures S6C and S6D ).
To corroborate that RBPJK exerts repression of miR-222/221 in the presence of MITF, we employed ChIP analysis to monitor markers of chromatin activity in the melanoma cell lines before and after RBPJK depletion by siRBPJK. In cells expressing high MITF levels, RBPJK depletion led to a decrease in H3K27me3 modification and increase in H3K4me3 modification at the miR-222/221 promoter (p < 0.05), indicating de-repression ( Figure 6B ). Conversely, in cells with low MITF expression, RBPJK depletion led to a modest increase in H3K27me3 modification and significant increase in H3K4me3 modification (legend continued on next page) ( Figure 6B ). As a negative control, RBPJK depletion was not accompanied by any changes in either H3K27me3 modification or H3K4me3 modification at the Actin promoter ( Figure S6E ). As expected, occupation of the miR-222/221 promoter and the control HES1 promoter by RBPJK was decreased upon siRBPJK treatment ( Figure S6F ) and RBPJK did not bind downstream ( Figure S5E ). We also used ChIP analysis to examine the level of RNA Polymerase II (Pol II) bound to the miR-222/221 promoter before and after RBPJK depletion. Pol II occupancy of the actin gene demonstrated no change upon RBPJK depletion (Figure 6C) . In contrast, siRBPJK treatment of cells with high MITF expression was observed to result in higher Pol II occupancy at the miR-222/221 promoter accompanied by decreased H3K27me3 modification ( Figures 6B and 6C) . Overexpression of RBPJK in cells with high MITF levels was observed to decrease luciferase expression of miR-222/221 promoter reporter in an E-Box-dependent manner ( Figure 6D ). Furthermore, MITF-mediated repression of luciferase expression was eliminated when the four R-Box sites were mutated in cells with low MITF levels ( Figure 6D ). As control, luciferase expression driven by a miR-222/221 promoter with four mutated R-Boxes was not affected upon induction of Notch signaling ( Figure S6G ). Finally, we investigated if RBPJK cooperates with MITF to repress miR-222/221 expression via recruitment of the demethylase KDM5A (Liefke et al., 2010) . The miR-222/221 promoter was subjected to ChIP analysis before and after siKDM5A treatment. Indeed, depletion of KDM5A was observed to result in an increase in H3K4me3 modification consistent with de-repression ( Figure S6H ). Moreover, RBPJK depletion was found to be associated with decreased KDM5A occupancy at the miR-222/221 promoter and an increase in H3K4me3 modification ( Figure 6E ). Moreover, MITF-mediated transcriptional repression of the miR-222/221 promoter was lower in the presence of mutated KDM5A (H483A) (Klose et al., 2007 ) as compared to wild-type KDM5A ( Figure 6F ). However, no physical interaction between MITF and KDM5A was observed ( Figure S6I ). Taken together, these data support our model that MITF and RBPJK cooperate to mediate repression by recruiting the H3K4me3 demethylase KDM5A to the miR-222/221 promoter.
Notch Signaling Activates miR-222/221 Gene Expression via NCID-Mediated Abrogation of MITF /RBPJK Repression to Induce Invasion Next, we wanted to confirm that activation of miR-222/221 expression by Notch signaling is mediated by NICD interfering with this activity of MITF/RBPJK. To this end, the luciferase reporter driven by the miR-222/221 promoter was co-transfected with either MITF or NICD. We observed that MITF reduced, whereas NICD increased, luciferase expression ( Figure 7A) . Then, to substantiate a functional interaction between NICD and MITF, EMSA experiments were conducted which showed that MITF binding to the E-Box binding site on miR-222/221 promoter could be blocked by NICD ( Figure 7B) .
Next, we induced Notch signaling in melanoma cells by culturing on DLL1-coated plates. DLL1-induced activation was validated using a Notch reporter with 12 RBPJK binding sites upstream of fluorescent mCherry (Sprinzak et al., 2010) ( Figures  S7A and S7B ) and observed to be accompanied by induction of miR-222/221 expression ( Figure 7C ). As expected, treatment of melanoma cells with DAPT reduced levels of both mature and pre-miR-222/221 levels ( Figure 7C ). Conversely, melanoma cells overexpressing NICD exhibited increased levels of both mature and pre-miR-222/221 ( Figure S7C ).
Further support for the in vivo activity of Notch signaling in melanoma cells was derived from screening mRNA expression across a set of 88 melanoma samples . In line with our model, we found that the levels of Notch-related genes (NOTCH1-4, MAML1, FN1, and TIMP3) (Hoek et al., 2004; Pinnix and Herlyn, 2007; Thurber et al., 2011) were inversely correlated with levels of MITF and MITF-related genes (Levy et al., 2006) such as tyrosinase and TRPM1 ( Figure 7D ).
Next we sought to demonstrate that melanoma invasion promoted by Notch signaling is indeed dependent on miR-222/ 221. To this end, melanoma cells with high MITF expression (WM3682) transfected with various vectors were seeded on DLL1-coated plates and invasion-assayed. No invading cells were detected when WM3682 cells were treated with DAPT or when anti-miR-222/221 was expressed ( Figure 7E ). However, as expected, NICD overexpression imparted elevated invasive capability, which was partially abolished by anti-miR-222/221 ( Figure S7D ). Moreover, overexpression of MITF in Notchactivated cells was found to partially repress Notch-induced invasion as well as miR-222/221 upregulation ( Figure S7E ). Taken together, these data establish that Notch signaling is transduced by NICD/RBPJK/MITF and results in upregulation of miR-222/ 221 expression, which in turn promotes the invasive ability of melanoma cells.
To identify downstream targets of the NICD/RBPJK/MITF/ miR-222/221 axis, we cross-referenced microarray gene expression data (n = 88) for MITF positively correlated genes (p < 0.05), miR-221/222 predicted targets, and invasion-related genes ( Figure 7F and Table S2 ). Among (D) Pearson's correlation for the mRNA expression levels of each gene relative to MITF. mRNA levels were calculated using the microarray profiles of 88 melanoma cell lines . MITF and MITF-related genes are marked in green; Notch and Notch-related genes are marked in red. (E) WM3526 and WM3682 cells were transfected with anti222/221 or antagomiR control, treated with DAPT or DMSO, and seeded on DLL1-coated plates. An invasion assay was then performed. Error bars represent ± SEM, * indicates p < 0.05 (n = 4). the overlapping subset, six were downregulated upon NICD overexpression and two increased upon MITF overexpression ( Figures S7F and S7G ). The latter two are growth factor receptor-bound protein 10 (GRB10), which functions as an inhibitor of IGFR1 (Vecchione et al., 2003) and estrogen receptor-alpha (ESR1), a known target of miR-222/221 (Zhao et al., 2008) . Validation of GRB10 and ESR1 downregulation in melanoma cells were demonstrated upon co-culture with differentiated keratinocytes or upon seeding on DLL1-coated plates ( Figures S7H and  S7I ). Moreover, ESR1 activity was significantly decreased upon Notch signaling activation either by NICD expression or co-culture with differentiated keratinocyte (Figures S7J and S7K ). Luciferase reporters driven by GRB10 or ESR1 3 0 untranslated regions (3 0 UTRs), both WT and mutated at miR-222/221 binding sites, were utilized to validate these genes as targets of miR-222/ 221. These reporter gene studies confirmed that GRB10 is a direct target of miR-222/221 activated in response to Notch signaling, but that this regulation does not involve MITF (Figure 7G ). In contrast, ESR1 is indeed a downstream target of the NICD/RBPK MITF/miR-222/221 axis. Finally, knockdown of GRB10 and ESR1 phenocopies the effect of increasing miR-222 on melanoma invasive activity ( Figures S7L and S7M) . These indicate that miR-222/221 directly targets GRB10 or ESR1 to promote melanoma invasion.
Next, we sought to clinically demonstrate that this series of events occurs in situ when melanoma cells come into contact with differentiated keratinocytes. To this end, gene expression profiles of a series of in situ and invasive melanoma samples were compared (Satyamoorthy et al., 2001; Smith et al., 2005) . In line with our model, Notch-related genes were upregulated in the invasive samples, whereas miR-222/221 target genes (p27Kip1/CDKN1B, ESR1 and TRPS1) (Felicetti et al., 2008; Stinson et al., 2011; Zhao et al., 2008) were downregulated ( Figures  7H and S7N ). This evidence supports that invasion is indeed initiated by contact between differentiated keratinocytes and melanoma cells, contact that activates Notch signaling and upregulates miR-222/221 expression.
DISCUSSION
Cancer progression is classically considered to involve cumulative acquisition of mutations conferring proliferative advantage and, ultimately, invasive capabilities that enable metastasis. In this study, we report a mutation-independent mechanism that triggers melanoma invasion. We found that direct contact of melanoma cells with distal differentiated keratinocytes is sufficient to trigger invasion and a metastasis cascade via activation of Notch signaling and inhibition of MITF transcriptional activity.
MITF appears to have contradictory roles in melanoma. MITF was previously defined as a melanoma oncogene (Garraway et al., 2005) that promotes neoplastic proliferation and tumor survival (Dynek et al., 2008) . In contrast, MITF has also been shown to inhibit melanoma invasion (Levy et al., 2010) . Here we reveal that MITF can act as a transcriptional repressor, with its repression activity regulated by Notch signaling, findings that shed light on the contradictory role of MITF. A functional link between MITF and Notch signaling in both normal and malignant melanocytes has been suggested previously (Osawa and Fisher, 2008) , but here we provide evidence for the relationship and mechanistic insights that build on our earlier study demonstrating that RBPJK DNA binding sites are significantly enriched (p value < 1.3 3 10 À7 ) in known MITF target gene promoters (Tabach et al., 2013) . Namely, we demonstrate that RBPJK mediates the repressive ability of MITF and that Notch signaling activation removes MITF from the promoter, leading to miR-222/221 upregulation.
Van Kilsdonk et al. demonstrated that in reconstructed skin, physical interaction with keratinocytes induces melanoma invasion in a process involving metalloproteinase-9, but the molecular mechanism was not elucidated (Van Kilsdonk et al., 2010) . In accordance with the behavior of this model system, we show that the interaction between melanoma cells and differentiated keratinocytes does indeed trigger dermal invasion, and that this requires activation of Notch signaling activation. Interestingly, in order to learn whether the effect of differentiated keratinocyte on melanoma cells is long lasting, we have performed double staining of MITF and NICD in human melanoma specimens (Figure S7O ). Strong active Notch signaling was demonstrated in vertical melanoma (as in Figure 3B ). This indicates that although these melanoma cells are not in direct contact with differentiated keratinocytes, the Notch pathway is still activated. These data suggest that non-invasive melanoma cells, upon interaction with differentiated keratinocytes, were transformed into invasive cells with (1) long-lasting activation of Notch signaling, similar to that in highly invasive cells (WM3314 and WM1716; Figures S6C and S6D) and (2) downregulation of MITF, which is known to act as invasion inhibitor (Levy et al., 2010) .
In summary, this study highlights the critical role of the tumor microenvironment and the sometimes contradictory roles of key players in progression versus invasion. These findings emphasize the need for careful study of the complex molecular mechanisms in situ before selecting therapeutic targets.
EXPERIMENTAL PROCEDURES
Primary Cell Culture Primary normal human epidermal keratinocytes (NHEK, Promocell) were grown in low calcium (0.06 mM) growth medium (C-20011; Promocell) or in high calcium (1.2 mM) to induce differentiation for 5 days. Primary normal human fibroblasts were isolated from foreskin. Foreskin was placed on trypsin (epidermis in a supine orientation) and incubated at 4 C for 10 hr, then for 1 hr at 37 C. Epidermis and dermis were separated; dermis was grown in DMEM supplemented with 10% FBS and antibiotics. HUVEC cells (Promocell) were grown in endothelial cell growth medium (C-22011; Promocell). Plates coated with DLL1 (Sprinzak et al., 2010) were prepared at final concentration of 2 ng/ml DLL1.
Chromatin Immunoprecipitation
ChIP assays were performed as described previously (Levy et al., 2010) with MITF rabbit polyclonal antibody, rabbit anti-H3K4me3 (9725; Cell Signaling), anti-H3K27me3 (9756; Cell Signaling), and normal rabbit IgG (sc-2027) as a control. qPCR was carried out using primers listed in Table S3 .
Melanoma Co-culture GFP-expressing WM3682 melanoma cells were transfected with a mCherry reporter gene bearing an NICD-responsive element upstream. Forty-eight hours after transfection, cells were co-cultured for 24 hr with or without 10 mM DAPT (Sigma-Aldrich) at 1:5 ratio with differentiated keratinocytes, undifferentiated keratinocytes, fibroblasts, or endothelial cells.
Mice and Histopathology Analysis
Animal experiments were conducted with approval from the University of Tel Aviv Institutional Animal Care and Use Committee (M-11-053). Treated cells were injected subcutaneously to NOD-SCID-IL2gnull (Jackson Laboratory) at 10 weeks of age. Mice were sacrificed at week 6-10 after xenografting. Internal organs were fixed with 10% formalin and were paraffin embedded followed by H&E staining. For co-graft model, 5 days post co-culture, cells were mixed 1:1 with Matrigel (BD Biosciences, 356231) and subcutaneously injected into NSG mice.
In Situ Hybridization
Slide preparation and in situ analysis were performed as described before (Bell et al., 2014) . Probes (listed in Table S4 ) were DIG-labeled locked nucleic acid (LNA)-based oligonucleotides specific for miR-222 or miRNA scramble negative control (Exiqon).
miRNA/mRNA Expression Data Paired miRNA/mRNA expression data were generated as described (Bell et al., 2014) . The correlation between MITF expression and each miRNA was calculated using Pearson's coefficient.
RNA-Seq Experimental Analysis
Total RNA was extracted from melanoma upon seeding on DLL-coated plates as describe earlier. Small-RNA libraries for deep sequencing were prepared using the TruSeq Small RNA Library Preparation Kit (Illumina) according to manufacturer instructions and run on HiSeq 2500 system (Illumina), 50 np.
ACCESSION NUMBERS
The small-RNA-seq data have been deposited in NCBI's Gene Expression Omnibus (Edgar et al., 2002) under GEO: GSE69403.
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